ChinaAMC SSE STAR Biology and Medicine ETF (SHA:588130)
China · Delayed Price · Currency is CNY 1.073
-0.001 (-0.09%)
At close: Apr 13, 2026
6.55% (1Y)
| Assets | 63.83M |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 9,034,900 |
| Open | 1.077 |
| Previous Close | 1.074 |
| Day's Range | 1.066 - 1.082 |
| 52-Week Low | 0.957 |
| 52-Week High | 1.359 |
| Beta | n/a |
| Holdings | 53 |
| Inception Date | May 14, 2025 |
About 588130
588130.SS was created on 2025-05-14 by ChinaAMC. The fund's investment portfolio concentrates primarily on health care equity.
Asset Class Equity
Category Health Care
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 588130
Provider ChinaAMC
Index Tracked Shanghai Stock Exchange Science and Technology Innovation Board Biopharmaceutical Index - CNY - Benchmark TR Gross
Top 10 Holdings
48.44% of assets| Name | Symbol | Weight |
|---|---|---|
| Shanghai United Imaging Healthcare Co., Ltd. | 688271 | 9.99% |
| BeOne Medicines AG | 688235 | 6.41% |
| Shanghai Allist Pharmaceuticals Co., Ltd. | 688578 | 5.83% |
| Sichuan Biokin Pharmaceutical Co.,Ltd. | 688506 | 5.53% |
| APT Medical Inc. | 688617 | 4.27% |
| Shanghai Junshi Biosciences Co., Ltd. | 688180 | 3.80% |
| Suzhou Zelgen Biopharmaceuticals Co., Ltd. | 688266 | 3.56% |
| MGI Tech Co., Ltd. | 688114 | 3.15% |
| BrightGene Bio-Medical Technology Co., Ltd. | 688166 | 3.01% |
| RemeGen Co., Ltd. | 688331 | 2.87% |